Studying the interaction of the antibody-drug conjugate SYD985 with an anti-toxin antibody

Antibody-drug conjugates (ADCs) have been recognized as a promising new class of therapeutic agents for the treatment of cancer. In the generation of ADCs, cytotoxic small molecules are covalently attached to therapeutic antibodies thereby increasing their tumor cell killing capability. We have performed MicroScale Thermophoresis experiments to determine the Kd values for the interaction between fluorescently labeled antibody-drug conjugate (SYD985) and an anti-toxin (drug) antibody in phosphate buffer as well in human plasma. The data show that MicroScale Thermophoresis is a powerful tool for the study of antibody-antigen interactions in standard buffers as well as complex bioliquids.

Previous Article
Mystery solved. A protein’s unfolded intermediates can bind to ligands and impact affinity
Mystery solved. A protein’s unfolded intermediates can bind to ligands and impact affinity

Binding of ligands to proteins can be characterized by several biophysical methods. Chemical denaturation i...

Up next
Integrated fragment-based approach reveals enzymatic inhibitors with potential therapeutic application
Integrated fragment-based approach reveals enzymatic inhibitors with potential therapeutic application

Indoleamine 2,3 dioxygenase 1 (IDO1) is an heme-containing enzyme that catalyses the conversion of L-Trypto...

Have a question about Monolith?

Contact Specialist